Portfolio comparison
Gilead Sciences Inc vs Merck Sharp and Dohme LLC
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Gilead Sciences Inc
Patents indexed
3
Year range
2013 – 2017
Most recent
2017
biotechpharmaceutical
Top Patents3 enriched
US 8592397· 2013
How Gilead Made a Stable HIV Pill Combining Two Medicines
US 9216996· 2015
Gilead's Chemical Compounds for Treating HIV Infections
US 9744181· 2017
How Gilead Stabilized the HIV Combination Pill Truvada
Activity by Decade
2010s3
Company B
Merck Sharp and Dohme LLC
Patents indexed
1
Year range
2018
Most recent
2018
biotechpharmaceutical
Top Patents1 enriched
US 10028963· 2018
How to Treat Severe Lung Infections Using Ceftolozane and Tazobactam
Activity by Decade
2010s1
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.